Abstract
FRI0156 A PHASE 1, SINGLE AND MULTIPLE ASCENDING DOSE STUDY OF TAS5315—A NOVEL HIGHLY SELECTIVE INHIBITOR OF BRUTON’S TYROSINE KINASE—IN HEALTHY MALE VOLUNTEERS
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have